Long

CADILA HEALTHCARE

Aggiornato
READY FOR NEXT SPRINT, SUBMITTED DATA OF TRIALS TO GOVERNMENT AND CROSSING RECENT HIGHEST CLOSING WITH VOLUMES. NEWS OF VACCINE APPROVAL IN NEXT WEEK MAY BE. TARGET IS UNCHARTED.
KEEP SUPPORT AT 630, FOR POSITIONAL VIEW.
Nota
Stoploss Hit
cadilaCADILAHCcadilahclongcadilahctradecadilahealthcareChart PatternsTechnical IndicatorsTrend Analysis

Declinazione di responsabilità